Breakthrough trial aims to save babies from Malaria's hidden threat
NCT ID NCT04336189
Summary
This large study tested whether combining two malaria prevention drugs works better than using either drug alone to protect pregnant women and their babies. Researchers enrolled 2,757 HIV-negative pregnant women in Uganda and randomly assigned them to receive different monthly preventive treatments. The goal was to find the safest, most effective approach to prevent malaria infections and reduce risks like low birth weight, premature birth, and infant death.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Infectious Diseases Research Collaboration Clinic - Masafu Hospital
Masafu, Busia, Uganda
Conditions
Explore the condition pages connected to this study.